Company Filing History:
2 out of 3,446 
2 out of 1,552 
Years Active: 2009-2011
Title: Christelle Bourgeois: Innovator in Recombinant Protein Research
Introduction
Christelle Bourgeois is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of recombinant proteins, holding 2 patents that showcase her innovative approaches to modifying protein activity and stability.
Latest Patents
One of her latest patents is titled "Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins." This patent discloses a method for producing a polypeptide with modified activity or stability by replacing an arginine residue capable of being ADP-ribosylated with a tryptophan or a phenylalanine. In one embodiment, the patent provides compositions that include polypeptides, such as alpha defensin, with arginine-to-tryptophan or arginine-to-phenylalanine substitutions. Additionally, methods are disclosed for modifying an immune response in a subject.
Career Highlights
Christelle Bourgeois has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Massachusetts. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Throughout her career, Christelle has collaborated with notable colleagues, including Joel Moss and Linda Stevens. These collaborations have further enriched her research and innovation in the field.
Conclusion
Christelle Bourgeois is a remarkable inventor whose work in recombinant proteins has the potential to impact various applications in biotechnology and medicine. Her innovative methods and collaborations highlight her dedication to advancing scientific knowledge and improving health outcomes.